Brainstorm Cell Therapeutics Inc. is a biotechnology company focused on developing innovative cellular therapies for neurodegenerative diseases. It primarily concentrates on the advancement of its proprietary stem cell-based platform technology, NurOwn, which is designed to treat severe, debilitating conditions like Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Parkinson's Disease. The technology involves the differentiation of autologous mesenchymal stem cells into cells that secrete neurotrophic factors, which are believed to support nerve growth and survival. In the broader market landscape, Brainstorm Cell Therapeutics plays a crucial role within the biotech sector, which is constantly exploring cutting-edge treatments to meet unmet medical needs. The company's work significantly impacts the healthcare industry by potentially providing new therapeutic options for patients who have limited alternatives. As a member of the biotechnology landscape, Brainstorm's innovations not only have the potential to transform individual lives but also signify advances in regenerative medicine, highlighting the importance of research and development in cellular and molecular therapies.
Website1325 Avenue of Americas
New York, NY, 10019
United States
Investors talking about BCLI also mention
What share of all stock conversation is about BCLI?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% 0 | 0% 0 | 0% 0 |
Of the messages about BCLI that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 22.22% | 22.22% | 51.79% -14.78 | ||
| Bearish | 0% | 77.78% | 77.78% | 48.21% +14.78 |
Of the messages about BCLI that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | — | — | — | 0% | ||
| Announcements | — | — | — | 72.59% | ||
| Controversies | — | — | — | 27.41% | ||
| Earnings | — | — | — | 0% | ||
| Macro | — | — | — | 0% | ||
| Technical Analysis | — | — | — | 0% |
Of the messages about BCLI, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 84.62% | 87.5% | 84.41% | ||
| Newcomers | 0% | 15.38% | 12.5% | 15.59% |